share_log

MusclePharm (OTCMKTS:MSLP) Stock Price Crosses Below 200-Day Moving Average of $0.20

MusclePharm (OTCMKTS:MSLP) Stock Price Crosses Below 200-Day Moving Average of $0.20

MusclePharm(场外交易代码:MSLP)股价跌破200日移动均线0.20美元
Defense World ·  2022/10/19 02:31

MusclePharm Co. (OTCMKTS:MSLP – Get Rating) shares crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.20 and traded as low as $0.11. MusclePharm shares last traded at $0.23, with a volume of 10,774 shares traded.

在周二的交易中,MusclePharm Co.(场外交易代码:MSLP-GET Rating)的股价跌破了200日移动均线。该股的200日移动均线切入位为0.20美元,交易价格低至0.11美元。MusclePharm的股票最新报0.23美元,总成交量为10,774股。

MusclePharm Price Performance

MusclePharm的性价比

The firm has a market capitalization of $7.65 million, a price-to-earnings ratio of -0.39 and a beta of 0.38. The firm has a 50 day moving average price of $0.17 and a 200-day moving average price of $0.20.

该公司的市值为765万美元,市盈率为-0.39,贝塔系数为0.38。该公司的50日移动均线价格为0.17美元,200日移动均线价格为0.20美元。

About MusclePharm

关于MusclePharm

(Get Rating)

(获取评级)

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products.

公司在美国和国际上开发、制造、营销和分销运动营养品和营养补充剂。该公司提供一系列高性能粉末、胶囊、片剂、凝胶和随时可用的零食。该公司的MusclePharm品牌产品组合包括战斗蛋白粉和战斗挤压蛋白棒;以及支链氨基酸、肌酸、谷氨酰胺、肉碱、共轭亚油酸、鱼油、多种维生素和其他产品等基本补充剂。

Recommended Stories

推荐故事

  • Get a free copy of the StockNews.com research report on MusclePharm (MSLP)
  • Does J&J Have Enough Alpha to Be a Solid Low Beta Stock?
  • This Mid Cap Energy Stock is a 10-Bagger...And May Not Be Done
  • Should You Make a Reservation in Marriott International Stock?
  • The Outperforming Software Stock No One is Talking About
  • Will Goldman Sachs' Earnings & Revenue Beats Lift Sector Higher?
  • 免费获取StockNews.com关于MusclePharm的研究报告(MSLP)
  • 强生是否有足够的阿尔法成为稳定的低贝塔股票?
  • 这只中型股能源股是一只10-Bagger……可能做不到
  • 您需要在万豪国际酒店预订吗?
  • 没有人谈论的表现优异的软件类股
  • 高盛的收益和收入超出预期会提振板块走高吗?

Receive News & Ratings for MusclePharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MusclePharm and related companies with MarketBeat.com's FREE daily email newsletter.

接受MusclePharm日报的新闻和评级-在下面输入您的电子邮件地址,即可通过MarketBeat.com的免费每日电子邮件时事通讯收到对MusclePharm和相关公司的最新新闻和分析师评级的每日简要摘要。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发